Stryker reported preliminary net sales at $2.2 billion for the fourth quarter, driven by a 46.8 percent increase in neurotechnology and spine sales. For the year’s end, the company reports preliminary net sales of $8.3 billion, a 13.5 percent increase over the previous year.
During the fourth quarter, the company repurchased 1.8 million shares at a cost of $83 million. In 2011, the company repurchased $622 million in shares.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
